Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse

This publication has 19 references indexed in Scilit:

• Calcium influx mediated by nicotinic receptors and voltage sensitive calcium channels in SK-N-SH human neuroblastoma cells
  Biochemical and Biophysical Research Communications, 1989
• Chronic nicotine treatment partly protects against the 1‐methyl‐4‐phenyl‐2, 3, 6‐tetrahydropyridine‐induced degeneration of nigrostriatal dopamine neurons in the black mouse
  Acta Physiologica Scandinavica, 1988
• Behavioral and biochemical effects of nicotine in an MPTP-induced mouse model of Parkinson's disease
  Pharmacology Biochemistry and Behavior, 1987
• Phosphorylation of the nicotinic acetylcholine receptor regulates its rate of desensitization
  Nature, 1986
• N‐Methyl‐4‐phenylpyridine (MMP⁺ together with 6‐hydroxydopamine or dopamine stimulates Ca²⁺ release from mitochondria
  FEBS Letters, 1986
• VI. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: Relationships between monoamine oxidase, MPTP metabolism and neurotoxicity
  Life Sciences, 1985
• Neurochemical and Histochemical Characterization of Neurotoxic Effects of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine on Brain Catecholamine Neurones in the Mouse
  Journal of Neurochemistry, 1985
• Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism
  Nature, 1984
• Liquid chromatographic analysis of catecholamines routine assay for regional brain mapping
  Life Sciences, 1976
• The Treatment of Post-Encephalitig Parkinsonism by Nicotine
  BMJ, 1926